tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Oren Livnat, 9 are a HOLD (3.54%), 245 are a BUY (96.46%).
Analyst Oren Livnat, carries an average stock price target met ratio of 48.39% that have a potential upside of 43.46% achieved within 260 days. Previously, Oren Livnat worked at HC WAINWRIGHT, JEFFERIES, JMP.
Oren Livnat’s has documented 482 price targets and ratings displayed on 30 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on AVDL, Avadel Pharmaceuticals PLC at 23-Oct-2025.
Analyst best performing recommendations are on VYNE (VYNE THERAPEUTICS).
The best stock recommendation documented was for VYNE (VYNE THERAPEUTICS) at 5/12/2020. The price target of $180 was fulfilled within 16 days with a profit of $49.68 (38.12%) receiving and performance score of 23.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Feb-2020
$38
$12.61 (49.67%)
$38
7 days ago
(01-Jul-2026)
8/15 (53.33%)
$12.97 (51.82%)
518
Buy Since 30-Apr-2020
$32
$6.76 (26.78%)
$30
2 months 7 days ago
(01-May-2026)
11/32 (34.38%)
$7.56 (30.93%)
261
Hold Since 26-Mar-2026
$25
$-0.24 (-0.95%)
$18
3 months 12 days ago
(26-Mar-2026)
2/6 (33.33%)
$1.69 (7.25%)
50
Buy Since 07-Nov-2025
$28
$2.76 (10.94%)
$25
8 months 1 days ago
(07-Nov-2025)
1/6 (16.67%)
$5.95 (26.98%)
29
Sell Since 19-Feb-2025
$24
$-1.24 (-4.91%)
$21
1 years 1 months 22 days ago
(16-May-2025)
2/3 (66.67%)
$-1.86 (-7.19%)
185
What Year was the first public recommendation made by Oren Livnat?
